Good evening :)

How to use scorecard? Learn more

AMC Logo

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Standard IDCW

IDCWRegular
24.220.41% (+0.10)
High
Low
Returns
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Mid-size Fund

Assets Under Mgmt: ₹ 1,073 Cr

Very High Risk

Principle investment will be at very high risk

Scorecard

Performance

Low

Hasn’t fared well - amongst the low performers in sub-category

Risk

Low

Stay at ease, amongst the lower risk funds

Cost

Avg

Market standard costs, nothing exciting

Composition

Avg

Average allocation strategy, nothing exciting

Red flags

Low

We got you covered, no major red flags identified

How to use scorecard? Learn more

Mid-size Fund

Assets Under Mgmt: ₹ 1,073 Cr

Very High Risk

Principle investment will be at very high risk

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Performance & Key Metrics

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Performance & Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
2.2843.431.10
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.7447.431.06

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Scheme InfoAditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Scheme Info

PlanPlanLock inLock inExit LoadExit Load
IDCW0 yrs1.00%
1% on or before 30D Nil after 30D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 1,000
Initial: ₹ 1,000 Incremental: ₹ 1,000
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Portfolio

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Asset Allocation

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Asset Allocation

Actual

Target

Dec 2025

Mar 2026

Jun 2026

Jul 2026

ACTUAL
Cash & EquivalentsEquity2.39%97.61%

Dec 2025

Mar 2026

Jun 2026

Jul 2026

Tickertape Separator

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Sector Distribution

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Sector Distribution

Diversified ChemicalsOthersMiscellaneousLabs & Life Sciences ServicesPharmaceuticals0.78 %1.64 %2.30 %21.10 %74.19 %

Dec 2025

Mar 2026

Jun 2026

Jul 2026

Tickertape Separator

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Sector Weightage

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Sector Weightage

Jun 25Sep 25Dec 25Mar 26Jun 26Jul 2675.91%73.46%76.78%77.97%75.20%74.19%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Current Holdings

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Current Holdings

Equity

Others

Sort holdings
  • Constituent
    Holding Weight
    3M Change

AMC Profile of Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv)

AMC Profile of Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv)

Aditya Birla Sun Life AMC Limited, is a joint venture between the Aditya Birla Group and the Sun Life Financial Inc. of Canada. The joint venture brings together Aditya Birla Group's experience in the Indian market and Sun Life's global experience.

Aditya Birla Sun Life AMC Limited, is a joint venture between the Aditya Birla Group and the Sun Life Financial Inc. of Canada. The joint venture brings together Aditya Birla Group's experience in the Indian market and Sun Life's global experience.

  • No.of Schemes

    88

  • Total AUM

    ₹ 4,36,165.93 Cr.

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Manager Details

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Manager Details

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Manager Profile

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Manager Profile

Qualification

B.Com, CFA, MBA

Past Experience

He has over 11years of work experience in Equity Capital Markets. He has also worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Funds Managed (5)
1Y Returns
12.44%
12.44%
3Y CAGR
14.13%
14.13%
Expense Ratio
1.02%
1.02%
1Y Returns
12.44%
12.44%
3Y CAGR
14.13%
14.13%
Expense Ratio
1.02%
1.02%
1Y Returns
4.14%
4.14%
3Y CAGR
7.87%
7.87%
Expense Ratio
1.08%
1.08%
1Y Returns
4.14%
4.14%
3Y CAGR
7.87%
7.87%
Expense Ratio
1.08%
1.08%
1Y Returns
16.35%
16.35%
3Y CAGR
Expense Ratio
1.06%
1.06%

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Manager Performance (0)

Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Manager Performance (0)

Loading...

Frequently asked questions

Frequently asked questions

  1. The current NAV of Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is ₹24.22, as of 8th September 2026.

  2. The Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) was launched on 10th July 2019. This mutual fund's past returns are as follows:
    • 1 Year Returns: 10.95%
    • 3 Year Returns: 13.24%
    • 5 Year Returns: 5.89%

  3. The top sectors Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) has invested in are as follows:
    • Pharmaceuticals | 74.19%
    • Labs & Life Sciences Services | 21.10%
    • Miscellaneous | 2.30%
    • Others | 1.64%
    • Diversified Chemicals | 0.78%
    This data is as on 8th September 2026.

  4. The top 5 holdings for Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) are as follows:
    • Torrent Pharmaceuticals Ltd | 9.94%
    • Sun Pharmaceutical Industries Ltd | 9.75%
    • Apollo Hospitals Enterprise Limited | 7.08%
    • Cipla Ltd | 4.56%
    • Aurobindo Pharma Limited | 4.29%
    This data is as on 8th September 2026.

  5. The asset allocation for Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is as follows:
    • Equity | 97.61%
    • Cash & Equivalents | 2.39%
    This data is as on 8th September 2026.

  6. The AUM (i.e. assets under management) of Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is ₹1073.85 Cr as of 8th September 2026.

  7. The expense ratio of Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) Plan is 2.28 as of 8th September 2026.

  8. The alpha ratio for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is 6.75

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. The volatility or standard deviation for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is 11.58

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. The Sharpe ratio for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is 1.10

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. The Sortino Ratio for the Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is 0.12

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. The PE ratio of Aditya Birla SL Pharma & Healthcare Fund-Reg(IDCW-Reinv) is 43.43, while category PE ratio is 47.43.